| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 30.570 | 39.599 | 57.215 | 74.785 | 81.083 | 81.484 | 88.703 | 94.213 | 90.710 |
| Total Income - EUR | - | 30.570 | 39.599 | 57.216 | 74.786 | 81.083 | 81.484 | 88.704 | 94.214 | 90.711 |
| Total Expenses - EUR | - | 12.204 | 19.313 | 30.501 | 36.243 | 35.247 | 32.010 | 31.772 | 40.345 | 56.414 |
| Gross Profit/Loss - EUR | - | 18.366 | 20.286 | 26.715 | 38.543 | 45.836 | 49.475 | 56.931 | 53.869 | 34.297 |
| Net Profit/Loss - EUR | - | 18.061 | 19.890 | 26.142 | 37.794 | 45.078 | 48.676 | 56.106 | 52.993 | 31.930 |
| Employees | - | 2 | 3 | 2 | 1 | 1 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Pintamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 30.553 | 21.401 | 12.597 | 4.106 | 0 | 72.526 | 72.121 |
| Current Assets | - | 18.919 | 21.278 | 16.940 | 32.434 | 43.599 | 50.993 | 76.040 | 77.044 | 50.249 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.379 | 4.958 | 7.557 | 10.283 | 8.168 | 7.866 | 7.541 | 68.529 | 36.808 |
| Cash | - | 16.540 | 16.320 | 9.383 | 22.151 | 35.432 | 43.127 | 68.499 | 8.515 | 13.441 |
| Shareholders Funds | - | 18.105 | 19.934 | 26.185 | 37.836 | 45.119 | 48.716 | 56.147 | 53.033 | 31.978 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 813 | 1.344 | 21.308 | 15.999 | 11.078 | 6.383 | 19.894 | 96.537 | 90.997 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Pintamed Srl